We continue to be optimistic abut Neuralstem Inc. . Lead candidate NSI-566 is being studied in ALS, SCI, and ischemic stroke - all significant unmet medical needs and large market opportunities.
http://seekingalpha.com/article/1282891-neuralstem-a-top-regenerative-medicine-play?source=feed
http://seekingalpha.com/article/1282891-neuralstem-a-top-regenerative-medicine-play?source=feed
No comments:
Post a Comment